10.3(top 8%)
Impact Factor
11.2(top 8%)
extended IF
255(top 1%)
H-Index
7.3K
authors
15.9K
papers
626.4K
citations
9.3K
citing journals
161.6K
citing authors

Most Cited Articles of Annals of Oncology

TitleYearCitations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 201320132K
Estimates of the cancer incidence and mortality in Europe in 200620071.8K
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer20161.7K
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 201420151.4K
Prevalence of pain in patients with cancer: a systematic review of the past 40 years20071.2K
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer20041.1K
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 201520151.1K
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up20171.1K
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 200920091K
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making2012984
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up2015962
Cancer incidence and mortality in Europe, 20042005909
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up2018897
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China2020838
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies2015828
Heating the patient: a promising approach?2002816
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up2016796
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic2019784
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 20052005783
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial2014780
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target2008771
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer2004754
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up2017751
Worldwide burden of cervical cancer in 20082011722
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up2014702